期刊文献+

菌谱分析法用于异质性甲氧西林耐药金黄色葡萄球菌检测

Population analysis as a useful method for isolation of herogeneous methecillin-resistant staphylococcus aureus
下载PDF
导出
摘要 目的初步建立异质性甲氧西林耐药金黄色葡萄球菌(heterogeneous m ethec illin-resistantStaphylococcus aureus,hetero-MRSA)检测方法,并对hetero-MRSA检测的临床意义进行探讨。方法采用菌谱分析法和K-B法,对60株经V itek 32检测为甲氧西林敏感金黄色葡萄球菌(m ethec illin susceptib leStaphylococcus aureus,MSSA)进行hetero-MRSA检测。结果菌谱分析法检出12株hetero-MRSA,K-B法检出2株hetero-MRSA。结论菌谱分析法对hetero-MRSA的检出率(20%)显著高于K-B法(3.3%)。MSSA对甲氧西林的异质性耐药不容忽视。 Objective To develop a new method for the isolation of heterogeneous methecillin-resistant staphylococcus aureus ( hetero- MRSA) and study its application in clinical practice. Methods Both the methods of disc agar diffusion and population analysis were used to detect hetero-MRSA from 60 strains of methecillin susceptible staphylococcus aureus(MSSA) which were identified by VITEK AMS. Results Twelve subclones of hetero-MRSA were isolated by population analysis ,while only 2 subclones were identified by disc agar diffusion. Conclusion Population analysis is an effective method for the isolation of hetero-MRSA, and its detection rate is higher than that of disc agar diffusion. The heterogeneous methecillin resistance of MSSA should not be overlooked by medical workers.
出处 《临床检验杂志》 CAS CSCD 北大核心 2006年第2期94-96,共3页 Chinese Journal of Clinical Laboratory Science
基金 苏州市科教兴卫青年专项基金(SWQ15)
关键词 异质性甲氧西林耐药金黄色葡萄球菌 菌谱分析法 药敏试验 hetero-MRSA population analysis antibiotics susceptibility test
  • 相关文献

参考文献7

二级参考文献39

  • 1CDC. Staphylococcus aureus resistant to Vancomycin-United States,2002. Morb Mortal Wkly Rep, 2002, 51(26): 565-567.
  • 2CDC. Public Health Dispatch: Vancoomycin-Resistant Staphylococcus aureusPennsylvania, 2002. Morb Mortal Wkly Rep, 2, 2002, 51(40): 902.
  • 3Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother, 1997, 40(1): 135-136.
  • 4Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 1997, 350(12): 1670-1673.
  • 5Sieradzki K, Villari P, Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of Staphylococci. Antimicrob Agents Chemother, 1998, 42(1):100-107.
  • 6Marchese A, Balistreri G, Tonoli E, et al. Heterogeneous vancomycin resistance in mehthiillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital . J Clin Microbiol, 2000, 38(2): 866-869.
  • 7Poly MC, Grelaud C, Martin C, et al. First clinical isolate of vancomycin-intermediate Stsaphylococcus in a French hospital. Lancet, 1998,351: 1212.
  • 8Viedma DG, Rabadan PM, Diaz M, et al. Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase-negative Staphylococcus isolated from catheters. J Clin Microbiol, 2000, 38(4): 1359-1363.
  • 9Wong SSY, Ho PL, Woo PCY, et al. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis, 1999,29: 760-767.
  • 10CDC. Investigation and Control of Vancomycin-Intermediate and resistant Staphylococcus aureus: A guide for health department and infection control personnel. Atlanta, GA. 2003 (Accessed at http://www. cdc.gov/ncidod/hip/ARESIST/visa-vrsa-guide. pdf)

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部